Grants
KEBIC PROJECT
REGIONE TOSCANA / FINANZIAMENTI REGIONALI PER RICERCA E SVILUPPO POR CREO FESR 2007-2013 BANDO UNICO R&S - LINEA A
- TITLE: Design of a knowledge database for biosimulation and increase in predictivity and translational productivity of preclinical data in the brain ischemy field.
The main goal of the project KEBIC is to create a knowledge database which collects and elaborates the results of a number of biological analysis performed on a brain ischemia animal model, integrating data and extrapolating the significance in their correlations. This integrated data system should allow the determination of the existence of such analytical parameters which could indicate the predictivity and the translation of the preclinical model into the human pathology.
TALCO PROJECT
REGIONE TOSCANA / FINANZIAMENTI REGIONALI PER RICERCA E SVILUPPO POR CREO FESR 2007-2013 BANDO NEGOZIALE ATTIVITA’ 1.1 - LINEA DI INTERVENTO 1.1.C.
- TITLE: Cytotoxic cell line based Orphan Drug (TALL-104) against ovarian cancer
The goal of the project TALCO is to characterize the TALL-104 cell line from a molecular biological point of view to clarify the mechanisms of their cytotoxic activity and their ability to recognize cancer from normal cells , including their capability to reach the tumor site; in order to determine TALL-104 cell line efficacy in a specific pathology like ovarian cancer, through both in vitro or in vivo on animal model studies. Moreover, to confirm the efficacy and safety in a clinical trial with 40 patients affected by such pathology. The achievement of these goals should result in the availability of a new advanced and innovative therapy, extremely valuable in comparison to current existing therapies in this field, including the autologous cell therapies. In fact, TALL-104 could be the first heterologous cell therapy to be developed across the world.